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Cell-mediated adaptive immunity is critical for host
defense, but little is known about T cell behavior
during delivery of effector function. Here we inves-
tigate relationships among antigen presentation,
T cell motility, and local production of effector cyto-
kines by CD4+ T cells within hepatic granulomas trig-
gered by Bacille Calmette-Gue´rin or Mycobacterium
tuberculosis. At steady-state, only small fractions
of mycobacteria-specific T cells showed antigen-
inducedmigration arrestwithin granulomas, resulting
in low-level, polarized secretion of cytokines. How-
ever, exogenous antigen elicited rapid arrest and
robust cytokine production by the vast majority of
effector T cells. These findings suggest that limited
antigenpresentation and/or recognitionwithin granu-
lomas evoke amuted T cell response drawing on only
a fractionof thehost’s potential effector capacity.Our
results provide new insights into the regulation of
host-protective functions, especially how antigen
availability influences T cell dynamics and, in turn,
effector T cell function during chronic infection.
INTRODUCTION
During the typical adaptive immune response to an infectious
agent, T cell interactions with cognate antigen-bearing dendritic
cells (DCs) in secondary lymphoid organs induce a program of
proliferation and differentiation resulting in production of an
effector T cell population with the capacity to home to sites of
inflammation and produce factors critical for containment and/or
clearance of the infection. This targeted delivery of effector func-
tion is dependent on antigen-specific interactions with antigen-
presenting cells (APCs) within the infected tissue. Elucidatingthe relationship between effector T cell-APC interactions at sites
of infection and the subsequent expression of effector molecules
by T cells is critical for deciphering the basis of productive and
nonproductive adaptive immune responses and for advancing
our capacity to develop new vaccines that rely on such cell-
mediated responses.
T cell-mediated immunity plays a major role in host defense
against intracellular microbial pathogens. Infection with Myco-
bacterium species such asM. tuberculosis (Mtb) induces forma-
tion of granulomas, agglomerations of inflammatory myeloid
cells and effector lymphocytes considered crucial for control
of mycobacterial replication, and maintenance of the infection
in an asymptomatic state. Past studies have examined the static,
spatial distribution of cells within these lesions, providing insight
into the role(s) played by intragranuloma cell populations in
effective resistance to bacterial growth and dissemination (Sa-
unders and Britton, 2007; Ulrichs and Kaufmann, 2006). Clearly,
ab T cell receptor (TCR)+CD4+ T cells are critical for generating
protective responses against mycobacterial infections (Caruso
et al., 1999; Ladel et al., 1995; Mogues et al., 2001), at least in
part based on their ability to locally produce inflammatory cyto-
kines such as IFN-g and TNF-a that enhance antimicrobial
capacities of infected macrophages (Flynn and Chan, 2001).
However, the dynamics of effector T cells migrating through
and within granulomas, the frequency with which these lympho-
cytes are activated to full effector functionality, and the precise
location of effector molecule delivery are all largely unstudied
features of this critical adaptive immune response.
Until recently, the tools necessary to address these questions
have been limited. However, advanced dynamic imaging
methods now permit extending the knowledge gained from
ex vivo or indirect in vivo studies to direct observation of immune
cell behavior and function within complex tissues. One major
application of such intravital microscopy (IM) techniques has
been the analysis of naive T cell motility during antigen-specific
activation by DCs in lymph nodes (LNs) (Bousso and Robey,
2003; Mempel et al., 2004; Miller et al., 2002, 2004; Stoll et al.,
2002). Among other findings, these studies characterized theImmunity 34, 807–819, May 27, 2011 ª2011 Elsevier Inc. 807
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cases, frank migration arrest resulting from antigen-specific
T cell-APC interactions, thereby establishing the utility of IM for
probing antigen presentation in situ (Bousso, 2008). More
recently, imaging studies involving infection of the liver, brain,
and skin with various pathogens or during autoimmune pro-
cesses have begun to address the sequence of interactions
between APCs and antigen-specific effector T cell subsets in
nonlymphoid sites (Bartholoma¨us et al., 2009; Beattie et al.,
2010; Fife et al., 2009; Filipe-Santos et al., 2009; Kawakami
et al., 2005; Kim et al., 2009; Matheu et al., 2008; Schaeffer
et al., 2009; Wilson et al., 2009). The findings of these recent
analyses are generally in agreement with the phenomenon first
observed during T cell priming in LNs, namely that T cells display
a constrained migratory pattern and/or arrest on APCs upon
antigen encounter, although the alterations in effector T cell
motility in inflamed sites are reportedly more subtle and hetero-
geneous than during naive T cell activation in lymphoid tissues.
Although these efforts have partially characterized the
dynamic behavior of effector T cells at sites of chronic infection,
there remains a paucity of information regarding the coupling of
T cell motility with the execution of effector function. Importantly,
issues such as the fraction of effectors that are actively
producing cytokines, the amount of cytokine production by
such antigen-triggered cells, the polarity or lack thereof in the
secretion of the effector molecules, and the kinetic relationship
between changes in cell dynamics instigated by peripheral
antigen recognition and the production of effector molecules
are all critical aspects of the adaptive T cell response in tissues
that are largely unexplored.
To begin to address these issues, we utilized multiphoton IM
and flow cytometry to explore the process of antigen recognition
by mycobacteria-specific CD4+ T cells within hepatic granu-
lomas. We showed that initial recruitment into and short-term
retention of T cells within granulomas was independent of
antigen recognition. Unexpectedly, antigen-specific and non-
specific T cell populations displayed only minor differences in
motility after recruitment into granulomas, a finding that corre-
lated with an extremely low frequency of mycobacteria-specific
T cells actively producing low amounts of IFN-g and/or TNF-a
within these lesions. These data suggest that for the vastmajority
of antigen-specific CD4+ T cells migrating within amycobacterial
granuloma, local antigen presentation levels are insufficient to
induce migrational arrest followed by polarized cytokine secre-
tion. Our findings provide new insight into the substantial differ-
ence between ex vivo studies of T cell cytokine production by
using maximal TCR stimulation and the actual amounts of cyto-
kine elicited in response to physiological amounts of antigen
presentation and point to the value of an increasing emphasis
on a quantitative assessment of effector function in vivo to
develop a better understanding of the pathways regulating
host defense.
RESULTS
Antigen-Independent Recruitment Followed by Antigen-
Dependent Activation of Effector T Cells
We previously demonstrated that activated, antigen nonspecific
effector CD4+ T cells are rapidly recruited into mycobacterial808 Immunity 34, 807–819, May 27, 2011 ª2011 Elsevier Inc.granulomas after adoptive transfer into infected animals (Egen
et al., 2008). To examine the influence of antigen recognition
on T cell behavior in this environment, we cotransferred dif-
ferentially labeled, in vitro stimulated effector T cells derived
from ovalbumin-specific OT-II TCR transgenic RAG1-deficient
(OT-II) mice (Barnden et al., 1998) and mycobacterial antigen
Ag85b-specific p25 TCR transgenic RAG1-deficient (p25) mice
(Tamura et al., 2004) into animals infected 2 weeks earlier with
an intravenous (i.v.) injection of 3 3 106 BCG or recombinant
BCG-overexpressing Ag85b (rBCG30) (Horwitz et al., 2000).
This latter strain was used to examine antigen-specific T cell
responses under conditions of increased antigen expression.
Animals were analyzed at 2 weeks postinfection (p.i.) based on
evidence for substantial hepatic granuloma formation at this
time point (Egen et al., 2008). Four hours after transfer, perfused
livers were examined with immunofluorescence microcopy. As
expected, both populations of effector T cells were efficiently re-
cruited into hepatic granulomas (Figure 1A). However, no signif-
icant difference was observed in their initial recruitment and/or
short-term retention (Figure 1B), suggesting that antigen does
not play a primary role in regulating T cell trafficking into and
out of granulomas over these time periods.
We next sought to determine whether mycobacteria-specific
T cells were receiving TCR signals upon entering granulomas.
In vitro stimulated OT-II and p25 T cells were cotransferred
into previously infected hosts as above. Four hours after transfer,
intrahepatic lymphocytes (IHLs) were analyzed by flow cytome-
try. This early time point was chosen based on our previous find-
ings showing that in vitro stimulated T cells do not begin accu-
mulating in large numbers within granulomas until 1–2 hr after
transfer (Egen et al., 2008). Thus, we reasoned that 4 hr was suffi-
cient for a bolus of effector T cells to enter a granuloma and
receive TCR signals but not sufficient for hepatic T cells to
have extensively trafficked within other infected tissues (e.g.,
spleen). As expected, OT-II T cells, whose cognate antigen oval-
bumin was not present in these animals, showed no evidence of
TCR-dependent activation after transfer into infected animals, as
indicated by a lack of increased surface CD69 expression,
arguing against antigen-independent upregulation of this
surface protein under these conditions. In contrast, p25 T cells
increased CD69 expression upon entry into infected livers, with
the most profound increase observed in rBCG30-infected
animals (Figures 1C and 1D). Thus, upon antigen-independent
entry into granulomas, a substantial fraction of antigen-specific
T cells engage antigenic complexes over relatively short periods
of time. The finding that in comparison to BCG, rBCG30 infection
induced higher CD69 expression by antigen-specific T cells also
suggests that in BCG-induced granulomas, antigen presentation
is not at saturating levels and can be driven higher by increasing
antigen quantity.
Limited Frequency of Sustained Antigen-Specific TCell-
APC Interactions within BCG-Induced Liver Granulomas
CD69 expression is typically induced in T cells by amounts of
antigen or strengths of TCR signaling substantially below that
necessary for cell division or cytokine production (Mempel
et al., 2004; Sancho et al., 2005; Skokos et al., 2007). Previous
studies have shown that T cells migrating through tissue
parenchyma show reduced velocity upon antigen receptor
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Figure 1. Antigen-Independent Accumula-
tion of T Cells in Mycobacterial Granulomas
(A) CMFDA-labeled OT-II and CMTPX-labeled p25
in vitro-stimulated T cells were transferred i.v. into
BCG-infected animals (2 weeks p.i.). Four hours
later, livers were fixed, sectioned, and stained with
an antibody specific for F4/80. Scale bar repre-
sents 50 mm.
(B) Numbers of transferred granuloma-associated
T cells were quantified from at least ten images per
mouse. Data points represent the ratio of p25 to
OT-II T cells for individual mice compiled from at
least three separate experiments.
(C) In vitro stimulated, dye-labeled T cells were
transferred into infected mice as in (A). Four hours
later, IHLs were purified from perfused livers,
stained with CD4 and CD69, and analyzed by flow
cytometry. Histograms show CD69 fluorescence
of OT-II or p25 gated cells.
(D) Median fluorescence intensity (MFI) of CD69.
Graph shows mean ± SD from three mice per
group and is representative of three similar
experiments. p values from a two-tailed t test are
shown (n.s., not significant).
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Effector T Cell Responses in Granulomasengagement, with robust TCR stimulation under such conditions
able to induce migration arrest (Bousso, 2008). Therefore, to
probe for local high-level antigen presentation within granu-
lomas, we used IM to examine the dynamic behavior of in vitro
stimulated antigen-specific and nonspecific granuloma-associ-
ated effector T cells shortly after their adoptive transfer into
previously infected animals. For some experiments, we utilized
BCG expressing RFP (BCGrfp) (Abadie et al., 2005) to allow visu-
alization of T cells in relation to individual mycobacteria present
in the imaged granuloma (Figure 2A).
We found that the majority of OT-II and p25 T cells showed
rapid migration that was constrained within the borders of the
relevant granuloma over several hours. Whereas some granu-Immunity 34, 807–lomas contained a modest fraction of
antigen-specific T cells displaying clear
differences in motility compared to non-
specific control cells, other granulomas
showed no obvious difference between
these two T cell populations (Movie S1
available online). Importantly, all granu-
lomas contained a predominant fraction
of highly motile p25 T cells, suggesting
that only a minor fraction of the mycobac-
teria-specific T cells received substantial
TCR signals over these time periods.
Quantitative cell tracking of OT-II and
p25 T cells revealed subtle differences in
mean velocity and arrest coefficient
(which better reveals the fraction of cells
undergoing antigen-induced stopping
behavior) (Figures 2B and 2C). Consistent
with their more pronounced upregulation
of CD69, p25 T cells showed slightly
greater reductions in motility in rBCG30-
infected compared to BCG-infectedanimals. However, the motility of OT-II T cells also appeared
slightly different between these two groups (Figures 2B and
2C), indicating that infection with these two agents may result
in granuloma environments that differ by more than just antigen
presentation levels.
To determine whether the above findings reflected low
amounts of antigen presentation or were due to some other
T cell-intrinsic or -extrinsic property that led to a dissociation
of the expected correlation between migration behavior and
strength of antigen recognition, we determined the maximal
degree of T cell-migrational arrest that could be observed
upon strong TCR engagement. Numerous APCs expressing
high amounts of MHC class II surround granuloma-associated819, May 27, 2011 ª2011 Elsevier Inc. 809
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Figure 2. Antigen-Specific and Nonspecific
T Cells Display Only Slight Differences in
Motility within Mycobacterial Granulomas
(A) CMFDA-labeled p25 and CMTPX-labeled OT-II
T cells were transferred i.v. into mice that had been
infected with BCGrfp (2 weeks p.i.). Four hours
later, animals were injected i.v. with BSA-647 to
label blood vessels and subjected to intravital
hepatic imaging. Scale bar represents 50 mm. See
also Movie S1.
(B and C) Quantification of velocity (B) and arrest
coefficient (C) for granuloma-associated p25 and
OT-II T cells in BCG- and rBCG30-infected mice.
Data points represent individual cells compiled
from at least four similar experiments with median
values indicated (p < 0.0001 for all OT-II versus
p25 comparisons; Mann-Whitney U test).
(D) Liver from a BCG-infected mouse bearing
fluorescent populations of p25 and OT-II T cells
was fixed, sectioned, and stained with anti-MHC II
and a nuclear dye. Scale bar represents 25 mm.
(E) Average instantaneous velocity over time of
OT-II (red line) and p25 (green line) granuloma-
associated T cells after injection of 25 mg of
cognate peptide antigens through an i.v. catheter.
Data are representative of three similar experi-
ments. See also Movie S2.
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Effector T Cell Responses in GranulomasT cells (Figure 2D). Therefore, we sequentially injected the
peptide antigens for which p25 (Ag85b240) and OT-II (OVA323)
T cells are specific, reasoning that rapid loading of surface or re-
cycling MHC class II molecules with exogenous peptides would
result in strong acute TCR stimulation. Indeed, within 1 min of
peptide injection, OT-II and p25 T cells each almost completely
arrested their migration in an antigen-specific manner (Figure 2E;
Movie S2). Taken together, these data indicate that antigen
presentation levels within granulomas are functionally limiting
and insufficient to support a high frequency of prolonged effector
T cell-APC interactions. These data also establish that migration
arrest is a cell-autonomous behavior under these conditions
directly linked to specific-antigen recognition.
Endogenously Primed Antigen-Specific Effector T Cells
Show Limited Migrational Arrest in Granulomas
Although adoptive transfer of in vitro generated effector T cells is
useful for comparing the dynamics of antigen-specific and810 Immunity 34, 807–819, May 27, 2011 ª2011 Elsevier Inc.nonspecific populations, there are
caveats to the interpretation of these find-
ings. First, the physiological relevance of
in vitro stimulated T cells to in vivo primed
effectors is unknown and second, the
large numbers of transferred T cells may
have little relation to the normal numbers
of endogenous effectors generated as
part of the typical response to infection.
Indeed, competition for occupancy of
and migration arrest on APCs has been
directly demonstrated within lymphoid
environments (Garcia et al., 2007). Thus,
to establish a more physiologically rele-vant system, we crossed the p25 TCR transgenic mice to
animals ubiquitously expressing EGFP (Schaefer et al., 2001),
maintaining the RAG1 deficiency (p25-EGFP). T cells derived
from thesemice retain fluorescence even after extensive prolifer-
ation and can thus be imaged after transfer into recipient animals
as naive cells prior to infection.
Small numbers of antigen-inexperienced p25-EGFP T cells
(2000) were transferred into uninfected hosts, whichwere subse-
quently infected with BCG, BCGrfp, or rBCG30. This low-dose
transfer should yield an EGFP-expressing population in the
host animals that is close to a physiological antigen-specific
precursor frequency (Hataye et al., 2006). At 2 weeks p.i.,
EGFP-expressing cells were easily detected in both the liver (Fig-
ure 3A; Figure S1; Movie S3) and spleen (Figure S1), indicating
a robust antigen-induced expansion in numbers. IM revealed
a dynamic population of p25-EGFP T cells, with velocities and
arrest coefficients that were similar in BCG- and rBCG30-
induced granulomas (Figures 3B and 3C). These findings differ
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A Figure 3. Limited Evidence of Antigen-
Specific Arrest in Mycobacterial Granu-
lomas after In Vivo Priming and Homing of
p25-EGFP T Cells
(A) Representative image from an intravital data set
of an animal that had been transferred with p25-
EGFP T cells and infected with BCGrfp. The paths
of T cell migration through the granuloma over
a 30 min time period are shown. Scale bar repre-
sents 30 mm. See also Movie S3.
(B and C) Quantification of velocity and arrest
coefficient for granuloma-associated p25-EGFP
T cells in BCG- and rBCG30-infected mice. Data
points represent individual cells compiled from at
least four separate experiments with median
values indicated (p = 0.0047 in B and p = 0.0475 in
C, Mann-Whitney U test).
(D) Instantaneous velocity of the p25-EGFP T cells
in a BCG granuloma after administration of Ag85b
peptide. See also Figure S1.
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Effector T Cell Responses in Granulomasfrom our earlier studies with in vitro stimulated T cells that re-
vealed modest differences in p25 motility in mice infected with
the two different strains. The reason for this discrepancy is
unknown but could stem from differences in T cell-activation
thresholds arising from the different stimulation conditions and/
or the fact that, in contrast to acutely transferred effector
T cells, the in vivo primed cells represent an asynchronous pop-
ulation that probably arrived in the granuloma over the span of
days or weeks as opposed to hours. Nevertheless, injection of
Ag85b240 peptide into BCG-infected animals during imaging
resulted in rapid and nearly total p25 T cell arrest, indicating
that these cells were also capable of responding to robust TCR
signals by limiting their migration (Figure 3D). These data again
suggest levels of antigen presentation within the granulomas
that are insufficient to induce robust TCR signaling in themajority
of effector T cells.
In Vivo Primed Antigen-Specific T Cells Display Limited
Effector Cytokine Production
The TCR signaling requirements for induction of T cell effector
responses at nonlymphoid sites of tissue inflammation are not
well characterized. Although our imaging data suggest that gran-
uloma-associated T cells are not undergoing robust TCR
signaling, they could still be receiving adequate stimulation for
cytokine production. This might be anticipated based on the
widespread upregulation of CD69 reported in Figure 1. Data
from previous studies have been interpreted to indicate that
T cells can add up sequential weak antigen-induced signals
during dynamic movement among a population of APCs and
reach a triggering threshold independent of migration arrest on
those APCs (Beltman et al., 2007; Celli et al., 2005; Henrickson
et al., 2008; Zheng et al., 2008).
To examine the relationship between granuloma-associated
T cell motility and effector cytokine production, we examined
IFN-g and TNF-a expression by hepatic p25 T cells after harvestImmunity 34, 807–from the liver. Adoptive transfers of p25-
EGFP T cells and infections were per-
formed as in Figure 3, except that 2 hrprior to analysis, animals received an i.v. injection of either
PBS or Ag85b240 peptide. Purification of IHLs was performed
in the presence of Brefeldin A (BFA) to block protein secretion
in situ and allowmeasurement of cytokine production by hepatic
T cells without the need for in vitro restimulation (Reinhardt et al.,
2003). Intracellular cytokine staining of IHLs from PBS-treated
mice allowed quantification of the frequency of hepatic p25
T cells that were actively producing cytokines at the time of
tissue harvest, whereas analysis of IHLs from Ag85b240
peptide-treated animals provided a measure of both the
maximal capacity of the hepatic p25 T cell population to produce
cytokines after robust stimulation and the cytokine detection
limit of the system.
These analyses revealed very low frequencies of hepatic p25
T cells actively producing IFN-g in BCG-infected animals. Such
cells were slightly increased in rBCG30-infected animals,
consistent with higher Ag85b expression. Importantly, after i.v.
Ag85b240 peptide treatment of BCG-infected mice, the vast
majority of p25 T cells showed IFN-g expression that was mark-
edly increased in amount on a per cell basis relative to PBS-
treated animals (Figures 4A–4D), indicating that nearly all these
T cells were competent to produce this cytokine. Traditional
in vitro PMA+ionomycin (P+I) restimulation revealed a similar
increase in cytokine production (Figures 4B–4D), suggesting
that in vivo peptide treatment was capable of detecting the full
extent of the effector response. Similar results were seen for
TNF-a (Figure 4E). These data demonstrate that despite a high
capacity for effector cytokine production, IFN-g and TNF-a
expression by hepatic p25 T cells is extremely limited within
the granuloma both in terms of the number of cells engaged in
such activity and the amount of cytokine being made per cell.
Given that Ag85b240 is a dominant peptide antigen for the
T cell response to BCG infection (Huygen et al., 1994), we sus-
pected that a substantial frequency of endogenous T cells would
respond to this antigen. Thus, to extend our findings beyond819, May 27, 2011 ª2011 Elsevier Inc. 811
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Figure 4. Antigen-Specific T Cells Show Limited Effector Function but Have High Effector Potential in Mycobacterial Granulomas
(A and B) Representative histograms gated on CD4+EGFP+ cells from p25-EGFP-bearing, BCG- or rBCG30-infected animals that had been injected with PBS or
Ag85b peptide 2 hr prior to analysis or restimulated with P+I in vitro.
(C and D) Quantification of the percentage and MFI of IFN-g+ p25 T cells. Graphs show mean ± SD from at least three mice per group and are representative of
three similar experiments. p values from a two-tailed t test are shown.
(E) Analysis of IFN-g and TNF-a expression by p25-EGFP. See also Figure S2.
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Effector T Cell Responses in GranulomasTCR transgenic T cells, we also analyzed ex vivo IFN-g expres-
sion by endogenous CD4+ T cells with and without i.v.
Ag85b240 peptide treatment. Similar to the above findings,
only low frequencies of IFN-g+ T cells were observed in the livers
of infected mice. Importantly, despite Ag85b240-specific T cells
representing only a fraction of the hepatic CD4+ T cell popula-
tion, we still detected a significant increase in cytokine produc-
tion after i.v. peptide treatment (Figures S2A and S2B). Thus,
although liver-homing T cells are capable of robust Th1 effector
cell responses after mycobacterial infection, this capacity for812 Immunity 34, 807–819, May 27, 2011 ª2011 Elsevier Inc.cytokine expression greatly exceeds what is actively induced
by antigen presentation within the granuloma.
The above experiments were focused at 2 week p.i., because
this was the earliest point at which we had observed the forma-
tion of large numbers of hepatic granulomas and a time of high
bacterial burden within the liver (Egen et al., 2008). Preliminary
studies performed at 1 week p.i. also revealed low amounts of
IFN-g production by endogenous CD4+ T cells (data not shown),
suggesting that effector T cells that home to the liver prior to
granuloma formation are not engaged in robust cytokine
Immunity
Effector T Cell Responses in Granulomasresponses. To exclude the possibility that the maximal granu-
loma-associated T cell response occurred at later time points,
we also examined cytokine responses at 4 weeks p.i., observing
an even lower frequency of IFN-g+CD4+ T cells compared to
2 weeks p.i. (Figure S2C). Together with our imaging observa-
tions, these data suggest that over the course of granuloma
development and maturation, T cell-extrinsic factors, such as
limited quantity and/or quality of T cell activation signals, result
in highly limited effector T cell responses within granulomas.
Polarized Secretion of Cytokine by Antigen-Specific,
Granuloma-Associated T Cells
In order to relate the small percentage of IFN-g-expressing
antigen-specific T cells observed by flow cytometry to the spa-
tio-temporal behavior of T cells seen via IM, we examined liver
sections from infected animals by immunofluorescence micros-
copy with antibodies directed against IFN-g. Our preliminary
studies suggested that this technique had a greatly reduced
sensitivity for detection of IFN-g production compared with
flow cytometry, and therefore we used rBCG30 infection in order
to maximize our chances of detecting small populations of
IFN-g+ cells. Adoptive transfers with p25-EGFP T cells were per-
formed as in Figure 3 and livers analyzed 2 weeks p.i. Although
no specific staining was observed with an isotype control anti-
body (Figure 5A), an IFN-g-specific antibody showed specific
staining within a subset of granuloma-associated p25 T cells,
where it appeared in a punctate staining pattern generally polar-
ized to one side of the cell (Figures 5B and 5C). The number of
IFN-g+ cells per granuloma was highly variable, with the majority
of granulomas containing no detectable staining (not shown).
Other granulomas contained small numbers of both p25 and
endogenous IFN-g producers (Figure 5B). In a smaller number
of cases, large clusters of IFN-g-producing p25 T cells could
be observed (Figure 5C; Movie S4).
We also compared the localization of mycobacteria and/or
mycobacterial antigenswithin the granuloma to the sites of polar-
ized effector T cell cytokine production by staining for Ag85b
protein. We first confirmed that the Ag85b antibody specifically
detected BCG within granulomas by staining liver sections
derived from BCGrfp-infected mice (Figure S3). The location of
BCGrfp and Ag85b were generally overlapping, although there
were some instances where Ag85b could be detected in the
absence of appreciable BCGrfp fluorescence, perhaps repre-
senting locations of bacterial death or sites where antigen has
been trafficked away from the bacteria. Although IFN-g staining
was generally polarized toward sites of Ag85b localization,
because of the large numbers of Ag85b puncta within the granu-
loma and the extremely high density of macrophages, which
limited accurate delineation of individual infected APC, we were
unable to generate quantitative correlations between these
events. Importantly, however, Ag85b staining was clearly de-
tectedat sites distal to both IFN-gproduction andp25T cell local-
ization, suggesting that other factors in addition to bacterial local-
ization, such as those affecting antigen processing and
presentation within a given APC, may be critical for regulating
sites of T cell-antigen recognition and upregulation of effector
function.Consistentwith this idea,we routinelyobserved reduced
levels of MHC class II within the central region of the granuloma
where the majority of mycobacteria are found (Figure S3).Limited Frequency of Sustained Antigen-Specific TCell-
APC Interactions within Mtb-Induced Liver Granulomas
To relate the above findings to amore clinically relevant infection,
we developed techniques for hepatic IM under biosafety level 3
(BSL-3) conditions, providing the ability to observe granuloma
dynamics after infection with virulent Mtb. We first confirmed
our ability to image Mtb-induced granulomas by using gene-
targeted mice in which EGFP had been placed under the control
of the endogenous Lysozyme M promoter (LysM-EGFP). The
latter animals were previously used to characterize macrophage
dynamics in hepatic BCG-induced granulomas (Egen et al.,
2008). IM at 2 weeks p.i. with an i.v. inoculation of 5 3 105 Mtb
revealed well-formed hepatic macrophage aggregates which,
consistent with our previously published data, formed a dense
network of largely static cells (Figure 6A;Movie S5). Thus, at least
in terms of myeloid cell populations, hepatic granuloma
dynamics appear similar for BCG and Mtb. These data argue
against bacterial virulence determinants that are missing in
BCG, such as region of differentiation-1 (RD1), being primary
regulators of granuloma-associated macrophage motility in our
system, as suggested by previous work with a zebrafish model
of mycobacterial infection (Davis and Ramakrishnan, 2009).
Adoptive transfer and imaging of in vitro stimulated, differen-
tially labeled effector OT-II and p25 T cells revealed robust
recruitment of both antigen-specific and nonspecific cell popula-
tions into Mtb-induced liver granulomas (Figure 6B; Movie S6).
However, only small differences were observed in the mean
velocity and arrest coefficient between these T cell populations
(Figures 6C and 6D). These data are consistent with our findings
via BCG infection and suggest that limited antigen presentation
within granulomas may be a general feature of mycobacterial
infections.
Limited Effector T Cell Cytokine Secretion within
Mtb-Induced Granulomas
We next examined whether the minimal antigen-induced T cell
arrest observed in Mtb-induced granulomas would correlate
with a paucity of effector cytokine production, as it had after
BCG infection. With a similar protocol to that described in Fig-
ure 4, we determined both the extent of and capacity for produc-
tion of IFN-g from p25 effector T cells isolated fromMtb-infected
animals in the presence of BFA. Again we detected a low
frequency of IFN-g+ p25 T cells directly ex vivo from Mtb-
infected animals (Figure 7A). Upon i.v. Ag85b240 peptide injec-
tion, the frequency of IFN-g+ cells and the amount of cytokine
per cell was dramatically increased (Figures 7A and 7C).
Ex vivo restimulation with P+I showed only a modest increase
in the frequency of IFN-g+ T cells compared with i.v. peptide
administration (Figures 7B and 7C). Thus, the limited arrest of
antigen-specific T cells observed in Mtb-induced granulomas
appears to translate to muted, submaximal local effector T cell
responses within these structures.
DISCUSSION
Mycobacterial containment relies on the ability of granulomas to
spatially and temporally colocalize critical cellular components
from the innate and adaptive arms of the immune system
to generate antibacterial effector responses. We previouslyImmunity 34, 807–819, May 27, 2011 ª2011 Elsevier Inc. 813
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Figure 5. In Situ IFN-g Staining in the Livers of rBCG30-Infected Mice
(A) Control stains for IFN-g and Ag85b. Livers from rBCG30-infected mice bearing p25-EGFP T cells were fixed, sectioned, and stained with purified rabbit IgG
and rat IgG1k as controls for anti-Ag85b and anti-IFN-g, respectively, and a nuclear counterstain. Images represent a single granuloma and show overlap of all
channels (left); overlap of red, green, and blue channels (center); and overlap of red and blue channels (right).
(B and C) Livers from rBCG30-infected mice bearing p25-EGFP T cells were fixed, sectioned, and stained with antibodies specific for Ag85b and IFN-g and
a nuclear counterstain. Two examples of individual granulomas with low (B) and high (C) numbers of IFN-g+ cells are shown. Granuloma borders are delineated
with a white line. Images on the right are magnified from boxed region in the central panel and show IFN-g staining from p25-EGFP T cells (white arrows) and an
endogenous T cell (purple arrow). The EGFP signal is removed in the lower panel for clarity.
Scale bars represent 25 mm in large panels and 5 mm in small panels. See also Movie S4.
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Effector T Cell Responses in Granulomasdemonstrated that these lesions in infected mice consist of
a largely static macrophage network that supports the rapid
recruitment and constrained localization of a highly motile
effector T cell population (Egen et al., 2008). Communication
between these two cell types is critical for the antimycobacterial
response and consists in part of antigen presentation to T cells
by infected macrophages and possibly DCs and the subsequent814 Immunity 34, 807–819, May 27, 2011 ª2011 Elsevier Inc.local activation and production of macrophage-stimulating cyto-
kines by the T cells (Flynn and Chan, 2001).
By using a well-established liver infection model, we demon-
strated that few potential effector T cells were stimulated suffi-
ciently by antigen at any one time within a mycobacterial granu-
loma to elicit inflammatory cytokine production and that this low
frequency correlated with the paucity of antigen-specific T cells
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Figure 6. Intravital Imaging of Mtb-Infected Animals Reveals Limited Antigen Recognition by p25 T Cells
(A) LysM-EGFP animals were subject to intravital hepatic imaging 2 weeks after i.v. infection with Mtb. See also Movie S5.
(B) CMTPX-labeled p25 and CMFDA-labeled OT-II T cells were transferred i.v. into mice that had been infected with Mtb 2 weeks earlier and imaged 4 hr later.
Scale bars represent 50 mm. See also Movie S6.
(C and D) Quantification of velocity and arrest coefficient for granuloma-associated p25 and OT-II T cells in Mtb-infected mice. Data points represent individual
cells compiled from at least four separate experiments with median values indicated (p < 0.0001 in C and p = 0.0003 in D, Mann-Whitney U test).
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the T cells were capable of showing migration arrest and re-
spondingwith amuch higher amount of per cell cytokine produc-
tion if confronted with artificially raised amounts of antigen. From
these data we conclude that, despite being sufficient for con-
straining the infection, the display of antigenic complexes by
the myeloid compartment within a granuloma is functionally
limited, such that at any moment, only a small number of
T cells can be triggered to arrest migration and produce relatively
modest levels of cytokines.
We speculate that these data via a hepatic infection model are
highly relevant to and predictive of events that occur during more
physiologically relevant pulmonary infections with Mtb. Indeed,
systemic infectionmodelshavebeenusedextensively toexamine
the cellular andmolecular pathways involved in host responses to
Mtb.However, similar experiments in low-doseaerosolMtb infec-
tion models will be an important step in determining the extent to
which our findings relate to the pathogenesis of human tubercu-
losis. In addition, our studies primarily examined the effector
response to a single mycobacterial antigen via a TCR transgenic
adoptive transfer model. Although we demonstrate that the bulk
population of endogenous CD4+ T cells behaves similarly to our
transferred population in terms of producing a muted, submax-
imal effector cytokine response, future work aimed at examining
T cell recognition of additional mycobacterial antigens is needed
to determine the extent to which our findings can be generalized.
Although often speculated upon, the correlation between
T cell motility and effector cytokine production has not beenwell established. Our analysis of local cytokine production within
the liver without additional in vitro restimulation revealed that,
despite highly efficient Th1 cell polarization during priming and
recruitment of mycobacterial antigen-specific effector T cells
into granulomas, only small numbers of these cells actively
produce IFN-g and/or TNF-a at any one time. Thus, cytokine
production appears linkedwithmotility and similar TCR signaling
thresholds may be in place for regulating both migration arrest
and upregulation of effector function. The rare T cells that do
receive sufficient signals to cause arrest synthesize cytokine
that, at least in the case of IFN-g, is secreted in a spatially polar-
ized fashion, presumably resulting in highly localized delivery of
the effector protein to limited numbers of target APCs. These
data are consistent with previous findings demonstrating polar-
ized secretion of IFN-g by CD8+ T cells toward virally infected
targets in the brain (Barcia et al., 2008). Interestingly, we also
observed rare cases of clustered cytokine-producing T cells,
suggesting the existence of extremely localized regions of
more robust antigen presentation within some granulomas.
These data are reminiscent of previous findings showing hetero-
geneity and local variation in T cell responses to Leishmania
major-infected cells in the skin (Filipe-Santos et al., 2009).
Numerous studies have identified mycobacterial pathways
capable of limiting antigen presentation by infected cells, espe-
cially via the MHC class II pathway (Harding and Boom, 2010).
In addition, downregulation of costimulatory molecules from the
surface of APCs and upregulation of inhibitory receptors capable
of locally suppressing the T cell response could also result inImmunity 34, 807–819, May 27, 2011 ª2011 Elsevier Inc. 815
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Figure 7. Antigen-Specific T Cells Show Limited Effector Function but High Effector Potential in Mtb-Induced Granulomas
(A) Animals were treated as in Figure 4 except they were infected with Mtb. Representative histograms gated on CD4+EGFP+ cells from p25-EGFP-bearing
infected animals that had been injected with PBS or Ag85b peptide 2 hr prior to analysis.
(B) IHLs were restimulated with P+I prior to analysis in order to detect maximum cytokine production.
(C) Quantification of percentage of p25 T cells expressing IFN-g. Graph shows mean ± SD from at least three mice per group and is representative of two similar
experiments. p values from a two-tailed t test are shown.
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Effector T Cell Responses in Granulomaslimited effector function within the granuloma (Schreiber et al.,
2010). It is likely that these immune evasion mechanisms are at
least partly responsible for the low effector CD4+ T cell arrest
and cytokine production observed in this study. However, other
factors may also influence the frequency of arrested and cyto-
kine-producing T cells detected in granulomas. During the initial
response to suboptimal TCR stimuli in the LN, naive T cells are
thought to integrate signals derived from multiple encounters
with APCs until a threshold is reached for arrest (Henrickson
et al., 2008;Mempel et al., 2004).Wedidobserveahigh frequency
of T cells showing signs of activation shortly after homing to the
infected liver but were unable to determine whether those
T cells receiving low levels of stimulatory signals became more
prone to arrest at later time points. Examination of in vitro gener-
ated effector T cell motility 12–24 hr posttransfer did not reveal
greater frequencies of arrested T cells compared to early time
points (not shown), but these experiments are difficult to interpret
because we were unable to prevent continual T cell homing into
the granuloma, thus leading to a temporally asynchronous popu-
lation at later time points. An additional possibility is that rare
Tcells encounteringhighamountsof cognateantigencouldeven-
tually desensitizeTCRsignalingpathways leading toan increased
threshold for arrest. Consistent with this idea, in vivo primed p25-
EGFP T cells that had homed to the granuloma over the course of816 Immunity 34, 807–819, May 27, 2011 ª2011 Elsevier Inc.days to weeks did not show the difference in motility between
BCG- and rBCG30-infected animals that was apparent in exper-
iments with acutely transferred effector T cells examined within
4 hr of their entry into these structures. Thus, an interesting possi-
bility is that effector T cells at sites of chronic inflammation can
adjust their stimulation threshold in order to strike a balance
between protection and immune-mediated tissue destruction.
Recently, several publications have concluded that effector
T cell arrest is rare at sites of chronic infection (Beattie et al.,
2010; Filipe-Santos et al., 2009; Schaeffer et al., 2009; Wilson
et al., 2009). Although these studies did not examine the relation-
ship between motility and cytokine production, together with our
study they suggest that limited long-term T cell-APC interactions
and correspondingly low levels of effector responses may be
a general feature of persistent infections and emphasize the
importance of determining whether bulk population behavior or
the dynamic properties of only a minor fraction of imaged cells
is the relevant parameter for measurement in such cases.
Comparing these data to future studies aimed at examining
effector T cell motility and effector cytokine production in acutely
resolving infection models should be informative, because we
speculate that rapidly resolving infections may induce more
robust effector T cell responses capable of effectively clearing
the invading pathogen.
Immunity
Effector T Cell Responses in GranulomasThe data presented here reveal that, relative to their potential,
effector T cells migrating within mycobacterial granulomas
produce an extremely muted response as a result of limited local
antigen presentation and/or recognition. An implication of these
findings is that strategies aimed solely at expanding the pool of
antigen-specific effector T cells in individuals infected with
some persistent pathogens, such as Mtb, may meet with limited
success, because there may be insufficient antigen present at
sitesof infection to support additional effector responses.Rather,
immunotherapeutic approachesdesigned to both increase levels
of local antigen presentation and maintain a high frequency of
effector T cells within infected tissues will probably have the
best chance at successfully reversing the course of the disease.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 OT-II TCR transgenic RAG1-deficient mice were from Taconic Labo-
ratories. C57BL/6 p25 TCR transgenic RAG1-deficient animals were kindly
provided by J. Ernst (New York University School of Medicine, New York)
(Wolf et al., 2008). C57BL/6 LysM-EGFP knockin animals were provided by
T. Graf (Center for Genomic Regulation, Barcelona, Spain) (Faust et al.,
2000). C57BL/6 mice and transgenic mice expressing EGFP under the control
of the human ubiquitin C promoter (Schaefer et al., 2001) were from Jackson
Laboratories. All mice were maintained in specific-pathogen-free conditions
at an Association for Assessment and Accreditation of Laboratory Animal
Care-accredited animal facility at the NIAID. All procedures were approved
by the NIAID Animal Care and Use Committee (National Institutes of Health,
Bethesda, MD).
Mycobacterial Strains and Infection
Mycobacterium tuberculosis strain H37Rv, Mycobacterium bovis BCG strain
Pasteur, RFP-expressing BCG strain Pasteur (Abadie et al., 2005), and
rBCG30 Tice overexpressing Ag85b (Horwitz et al., 2000) were expanded to
log phase onMiddlebrook 7H9 liquid medium supplemented with ADC (Difco),
washed, aliquoted in PBS, and stored at 80C until further use. BCG-RFP
and rBCG30 bacteria were grown in the presence of Hygromycin (Sigma).
Bacterial stocks were quantified on 7H11 agar supplemented with OADC
(Difco). For mycobacterial infections, animals were inoculated i.v. with 3 3
106 BCG or 5 3 105 Mtb in PBS.
In Vitro T Cell Stimulation and Adoptive Transfers
For in vitro generated effector T cells, LNs were disrupted by passing through
a 70 mm cell strainer (BD Biosciences). 13 106 of the isolated cells were stim-
ulated with 1 3 107 mitomycin C-treated C57BL/6 splenocytes in complete
RPMI 1640 (10% FCS, 2 mM L-glutamine, 50 mM 2-mercaptoethanol, and
penicillin/streptomycin) plus 2 mM ovalbumin 323-339 peptide (OT-II) or
Ag85b 240-254 peptide (p25) in each well of a 24-well plate. Two days after
stimulation, cells were expanded in the presence of 30 U/ml recombinant
human IL-2 (R&D systems) and used for experiments 6–7 days postactivation.
In vitro generated effector T cells were labeled with 1 mM CMTPX or CMFDA
(Invitrogen) for 15 min at 37C in HBSS. 13 107 of each cell type was injected
i.v. into recipient animals.
For antigen-inexperienced T cells, LN cells obtained from p25-EGFP mice
(>90%Vb11+CD4+ T cells) were transferred into noninfected recipient animals.
Each animal received 23 103 p25 T cells. Animals were infected12 hr later as
described above.
Cell Isolation and Flow Cytometry
For intrahepatic lymphocyte isolation, livers were perfused through the portal
veinwithRPMI+1%fetal calf serumcontaining0.25mg/mlofLiberaseCI (Roche)
and 0.05% DNase I (Boehringer Mannheim), excised, and digested for an addi-
tional 45 min at 37C. Cell suspensions were washed, resuspended in a 33%
isotonic Percoll (AmershamBiosciences), and centrifuged at 8003 g for 20min.
For analysis of adoptively transferred, in vitro stimulated effector T cells,
IHLs were stained with anti-CD4 Pacific Blue (Clone RM4-5), anti-CD3 AlexaFluor (AF) 647 (Clone 17A2). Anti-CD69 PE-Cy7 (Clone H1.2F3) was used in
some experiments. CMFDA- and CMTPX-labeled cells were detected in the
FITC and PE-Texas Red channels, respectively. For analysis of intracellular
cytokine production, cell suspensions were obtained as described above
except that 20 mg/ml of BFA (Sigma) was included in the digest buffer and
subsequent steps were performed in the presence of 5 mg/ml BFA. Cells
were stained immediately ex vivo or stimulated in vitro for 2 hr at 37C in the
presence of 20 ng/ml phorbol 12-myristate 13-acetate, 1 mM ionomycin, and
10 mg/ml of BFA (All from Sigma). Cells were surface stained with anti-CD4
Pacific Blue, anti-Vb11 biotin (Clone RR3-15), and anti-CD3 PerCP-Cy5.5
(Clone 145-2C11). Biotinylated antibodies were detected with Streptavidin
PE-Cy7. Cells were fixed with Cytofix buffer, permeabilized with Perm/Wash
buffer (BD Biosciences), and stained with anti-IFN-g AF647 (Clone XMG1.2)
and anti-TNF-aPE (CloneMP6-XT22). EGFPwas detected in the FITC channel
and isotype controls were used to determine background signals for intracel-
lular stains. Flow cytometric data were collected on an LSR II (BD Biosciences)
and analyzed with FlowJo software (TreeStar).
Intravital Multiphoton Microscopy
Surgical preparation of the liver was performed as described (Egen et al.,
2008). Liver sinusoids were visualized by injecting Texas Red-conjugated
bovine serum albumin (BSA-TR), AF647-conjugated BSA (BSA-647), or non-
targeted Quantum Dots 705 (Invitrogen) i.v. immediately prior to imaging.
For acute injection of peptide antigens during imaging, a catheter was placed
into the tail vein via a 30GA needle attached to PE-10 tubing (Becton Dickin-
son) and secured with Durapore Tape (Fischer Scientific). For BCG-infected
animals, images were acquired on an LSM 510 NLO multiphoton imaging
system (Carl Zeiss Microimaging) as described in (Egen et al., 2008). For
Mtb-infected animals, images were acquired on a TCS-SP2 MP inverted
confocalmicroscope (LeicaMicrosystems) located in a dedicatedBSL-3 suite,
with a 203/0.7 NA objective for imaging. Fluorescence excitation was
provided by a Chameleon Ti:Sapphire laser (Coherent). EGFP and RFP were
excited at 920 nm while CMFDA and CMTPX were excited at 820 nm. For
4-dimensional (4D) data sets, 3-dimensional stacks were captured every
1 min, unless otherwise specified.
Raw imaging data were processed with Imaris (Biplane). Automatic object
tracking via Imaris Spots was aided with manual corrections to retrieve cell
spatial coordinates over time that were analyzed in MatLab. Arrest coefficient
was defined as the percentage of time points a cell’s instantaneous velocity
was less than 2 mm/min. AfterEffects (Adobe) was used to produce video clips.
Immunofluorescence Staining
Livers were perfused with PBS followed by PLP buffer (0.05 M phosphate
buffer containing 0.1 M L-lysine [pH 7.4], 2 mg/ml NaIO4, and 10 mg/ml para-
formaldehyde), fixed for an additional 12 hr, and dehydrated in 30% sucrose
prior to embedding in OCT freezing media (Sakura Finetek). 16 mm sections
were cut on a CM3050S cryostat (Leica) and adhered to Superfrost Plus slides
(VWR). Sections were permeabilized and blocked in PBS containing 0.1%
Triton X-100 (Sigma) and 10%goat serum (Jackson Immunoresearch) followed
by staining in PBS containing 0.01% Triton X-100 and 5% goat serum. The
following antibodies were used: anti-MHC-II FITC (clone 2G9), anti-IFN-g
AF647 (Clone XMG1.2; BD Biosciences), anti-F4/80 AF647 (clone BM8;
Ebioscience), and anti-Ag85b (AbCam). Unconjugated primary antibodies
were stained with AF-conjugated secondary antibodies (Invitrogen). For
IFN-g detection, staining with a secondary goat anti-rat AF647 was used to
increase the signal. Nuclei were detected with Hoechst 33342 (Invitrogen).
Stained slides were mounted with Prolong Gold (Invitrogen) and images were
acquired on a LSM 510 or 710 confocal microscope (Carl Zeiss Microimaging).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and six movies and can be
found with this article online at doi:10.1016/j.immuni.2011.03.022.
ACKNOWLEDGMENTS
Wewould like to thank W. Kastenmuller, M. Gerner, N. Vrisekoop, and M. Clat-
worthy for helpful discussions and/or critical reading of the manuscript,Immunity 34, 807–819, May 27, 2011 ª2011 Elsevier Inc. 817
Immunity
Effector T Cell Responses in GranulomasO. Schwartz and L. Koo (Research Technology Branch/NIAID) for technical
assistance with intravital microscopy under BSL3 conditions, and A. Rinker, I.
Ifrim, and S. White for technical support. We are extremely grateful to J. Ernst
for providing valuable reagentsused in this study, aswell as for insightful discus-
sions, sharing of unpublished data, and helpful comments on the manuscript.
Thisworkwassupportedby the IntramuralResearchProgramof theNIAID,NIH.
Received: September 8, 2010
Revised: January 18, 2011
Accepted: March 2, 2011
Published online: May 19, 2011
REFERENCES
Abadie, V., Badell, E., Douillard, P., Ensergueix, D., Leenen, P.J., Tanguy, M.,
Fiette, L., Saeland, S., Gicquel, B., and Winter, N. (2005). Neutrophils rapidly
migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccina-
tion and shuttle live bacilli to the draining lymph nodes. Blood 106, 1843–1850.
Barcia, C., Wawrowsky, K., Barrett, R.J., Liu, C., Castro, M.G., and
Lowenstein, P.R. (2008). In vivo polarization of IFN-gamma at Kupfer and
non-Kupfer immunological synapses during the clearance of virally infected
brain cells. J. Immunol. 180, 1344–1352.
Barnden, M.J., Allison, J., Heath, W.R., and Carbone, F.R. (1998). Defective
TCR expression in transgenic mice constructed using cDNA-based alpha-
and beta-chain genes under the control of heterologous regulatory elements.
Immunol. Cell Biol. 76, 34–40.
Bartholoma¨us, I., Kawakami, N., Odoardi, F., Schla¨ger, C., Miljkovic, D.,
Ellwart, J.W., Klinkert, W.E., Flu¨gel-Koch, C., Issekutz, T.B., Wekerle, H.,
and Flu¨gel, A. (2009). Effector T cell interactions with meningeal vascular
structures in nascent autoimmune CNS lesions. Nature 462, 94–98.
Beattie, L., Peltan, A., Maroof, A., Kirby, A., Brown, N., Coles, M., Smith, D.F.,
and Kaye, P.M. (2010). Dynamic imaging of experimental Leishmania dono-
vani-induced hepatic granulomas detects Kupffer cell-restricted antigen
presentation to antigen-specific CD8 T cells. PLoS Pathog. 6, e1000805.
Beltman, J.B., Mare´e, A.F., and de Boer, R.J. (2007). Spatial modelling of brief
and long interactions between T cells and dendritic cells. Immunol. Cell Biol.
85, 306–314.
Bousso, P. (2008). T-cell activation by dendritic cells in the lymph node:
Lessons from the movies. Nat. Rev. Immunol. 8, 675–684.
Bousso, P., and Robey, E. (2003). Dynamics of CD8+ T cell priming by dendritic
cells in intact lymph nodes. Nat. Immunol. 4, 579–585.
Caruso, A.M., Serbina, N., Klein, E., Triebold, K., Bloom, B.R., and Flynn, J.L.
(1999). Mice deficient in CD4 T cells have only transiently diminished levels of
IFN-gamma, yet succumb to tuberculosis. J. Immunol. 162, 5407–5416.
Celli, S., Garcia, Z., and Bousso, P. (2005). CD4 T cells integrate signals deliv-
ered during successive DC encounters in vivo. J. Exp. Med. 202, 1271–1278.
Davis, J.M., and Ramakrishnan, L. (2009). The role of the granuloma in expan-
sion and dissemination of early tuberculous infection. Cell 136, 37–49.
Egen, J.G., Rothfuchs, A.G., Feng, C.G., Winter, N., Sher, A., and Germain,
R.N. (2008). Macrophage and T cell dynamics during the development and
disintegration of mycobacterial granulomas. Immunity 28, 271–284.
Faust, N., Varas, F., Kelly, L.M., Heck, S., and Graf, T. (2000). Insertion of
enhanced green fluorescent protein into the lysozyme gene creates mice
with green fluorescent granulocytes and macrophages. Blood 96, 719–726.
Fife, B.T., Pauken, K.E., Eagar, T.N., Obu, T., Wu, J., Tang, Q., Azuma, M.,
Krummel, M.F., and Bluestone, J.A. (2009). Interactions between PD-1 and
PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat.
Immunol. 10, 1185–1192.
Filipe-Santos, O., Pescher, P., Breart, B., Lippuner, C., Aebischer, T.,
Glaichenhaus, N., Spa¨th, G.F., and Bousso, P. (2009). A dynamic map of
antigen recognition by CD4 T cells at the site of Leishmania major infection.
Cell Host Microbe 6, 23–33.
Flynn, J.L., and Chan, J. (2001). Immunology of tuberculosis. Annu. Rev.
Immunol. 19, 93–129.818 Immunity 34, 807–819, May 27, 2011 ª2011 Elsevier Inc.Garcia, Z., Pradelli, E., Celli, S., Beuneu, H., Simon, A., and Bousso, P. (2007).
Competition for antigen determines the stability of T cell-dendritic cell interac-
tions during clonal expansion. Proc. Natl. Acad. Sci. USA 104, 4553–4558.
Harding, C.V., and Boom, W.H. (2010). Regulation of antigen presentation by
Mycobacterium tuberculosis: A role for Toll-like receptors. Nat. Rev. Microbiol.
8, 296–307.
Hataye, J., Moon, J.J., Khoruts, A., Reilly, C., and Jenkins, M.K. (2006). Naive
andmemory CD4+ T cell survival controlled by clonal abundance. Science 312,
114–116.
Henrickson, S.E., Mempel, T.R.,Mazo, I.B., Liu, B., Artyomov,M.N., Zheng, H.,
Peixoto, A., Flynn, M.P., Senman, B., Junt, T., et al. (2008). T cell sensing of
antigen dose governs interactive behavior with dendritic cells and sets
a threshold for T cell activation. Nat. Immunol. 9, 282–291.
Horwitz, M.A., Harth, G., Dillon, B.J., and Maslesa-Galic’, S. (2000).
Recombinant bacillus calmette-guerin (BCG) vaccines expressing the
Mycobacterium tuberculosis 30-kDa major secretory protein induce greater
protective immunity against tuberculosis than conventional BCG vaccines in
a highly susceptible animal model. Proc. Natl. Acad. Sci. USA 97, 13853–
13858.
Huygen, K., Lozes, E., Gilles, B., Drowart, A., Palfliet, K., Jurion, F., Roland, I.,
Art, M., Dufaux, M., Nyabenda, J., et al. (1994). Mapping of TH1 helper T-cell
epitopes on major secreted mycobacterial antigen 85A in mice infected with
live Mycobacterium bovis BCG. Infect. Immun. 62, 363–370.
Kawakami, N., Na¨gerl, U.V., Odoardi, F., Bonhoeffer, T., Wekerle, H., and
Flu¨gel, A. (2005). Live imaging of effector cell trafficking and autoantigen
recognition within the unfolding autoimmune encephalomyelitis lesion.
J. Exp. Med. 201, 1805–1814.
Kim, J.V., Kang, S.S., Dustin, M.L., and McGavern, D.B. (2009).
Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute
viral meningitis. Nature 457, 191–195.
Ladel, C.H., Daugelat, S., and Kaufmann, S.H. (1995). Immune response to
Mycobacterium bovis bacille Calmette Gue´rin infection in major histocompat-
ibility complex class I- and II-deficient knock-out mice: contribution of CD4
and CD8 T cells to acquired resistance. Eur. J. Immunol. 25, 377–384.
Matheu, M.P., Beeton, C., Garcia, A., Chi, V., Rangaraju, S., Safrina, O.,
Monaghan, K., Uemura, M.I., Li, D., Pal, S., et al. (2008). Imaging of effector
memory T cells during a delayed-type hypersensitivity reaction and suppres-
sion by Kv1.3 channel block. Immunity 29, 602–614.
Mempel, T.R., Henrickson, S.E., and Von Andrian, U.H. (2004). T-cell priming
by dendritic cells in lymph nodes occurs in three distinct phases. Nature
427, 154–159.
Miller, M.J., Wei, S.H., Parker, I., and Cahalan, M.D. (2002). Two-photon
imaging of lymphocyte motility and antigen response in intact lymph node.
Science 296, 1869–1873.
Miller, M.J., Safrina, O., Parker, I., andCahalan,M.D. (2004). Imaging the single
cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes.
J. Exp. Med. 200, 847–856.
Mogues, T., Goodrich, M.E., Ryan, L., LaCourse, R., and North, R.J. (2001).
The relative importance of T cell subsets in immunity and immunopathology
of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193,
271–280.
Reinhardt, R.L., Bullard, D.C., Weaver, C.T., and Jenkins, M.K. (2003).
Preferential accumulation of antigen-specific effector CD4 T cells at an antigen
injection site involves CD62E-dependent migration but not local proliferation.
J. Exp. Med. 197, 751–762.
Sancho, D., Go´mez, M., and Sa´nchez-Madrid, F. (2005). CD69 is an immuno-
regulatory molecule induced following activation. Trends Immunol. 26,
136–140.
Saunders, B.M., and Britton, W.J. (2007). Life and death in the granuloma:
Immunopathology of tuberculosis. Immunol. Cell Biol. 85, 103–111.
Schaefer, B.C., Schaefer, M.L., Kappler, J.W., Marrack, P., and Kedl, R.M.
(2001). Observation of antigen-dependent CD8+ T-cell/dendritic cell interac-
tions in vivo. Cell. Immunol. 214, 110–122.
Immunity
Effector T Cell Responses in GranulomasSchaeffer, M., Han, S.J., Chtanova, T., van Dooren, G.G., Herzmark, P., Chen,
Y., Roysam, B., Striepen, B., and Robey, E.A. (2009). Dynamic imaging of
T cell-parasite interactions in the brains of mice chronically infected with
Toxoplasma gondii. J. Immunol. 182, 6379–6393.
Schreiber, H.A., Hulseberg, P.D., Lee, J., Prechl, J., Barta, P., Szlavik, N.,
Harding, J.S., Fabry, Z., and Sandor, M. (2010). Dendritic cells in chronic
mycobacterial granulomas restrict local anti-bacterial T cell response in
a murine model. PLoS ONE 5, e11453.
Skokos, D., Shakhar, G., Varma, R., Waite, J.C., Cameron, T.O., Lindquist,
R.L., Schwickert, T., Nussenzweig, M.C., and Dustin, M.L. (2007). Peptide-
MHC potency governs dynamic interactions between T cells and dendritic
cells in lymph nodes. Nat. Immunol. 8, 835–844.
Stoll, S., Delon, J., Brotz, T.M., and Germain, R.N. (2002). Dynamic imaging of
T cell-dendritic cell interactions in lymph nodes. Science 296, 1873–1876.
Tamura, T., Ariga, H., Kinashi, T., Uehara, S., Kikuchi, T., Nakada, M.,
Tokunaga, T., Xu, W., Kariyone, A., Saito, T., et al. (2004). The role of antigenicpeptide in CD4+ T helper phenotype development in a T cell receptor trans-
genic model. Int. Immunol. 16, 1691–1699.
Ulrichs, T., and Kaufmann, S.H. (2006). New insights into the function of gran-
ulomas in human tuberculosis. J. Pathol. 208, 261–269.
Wilson, E.H., Harris, T.H., Mrass, P., John, B., Tait, E.D., Wu, G.F., Pepper, M.,
Wherry, E.J., Dzierzinski, F., Roos, D., et al. (2009). Behavior of parasite-
specific effector CD8+ T cells in the brain and visualization of a kinesis-associ-
ated system of reticular fibers. Immunity 30, 300–311.
Wolf, A.J., Desvignes, L., Linas, B., Banaiee, N., Tamura, T., Takatsu, K., and
Ernst, J.D. (2008). Initiation of the adaptive immune response to
Mycobacterium tuberculosis depends on antigen production in the local lymph
node, not the lungs. J. Exp. Med. 205, 105–115.
Zheng, H., Jin, B., Henrickson, S.E., Perelson, A.S., von Andrian, U.H., and
Chakraborty, A.K. (2008). How antigen quantity and quality determine T-cell
decisions in lymphoid tissue. Mol. Cell. Biol. 28, 4040–4051.Immunity 34, 807–819, May 27, 2011 ª2011 Elsevier Inc. 819
